Biobase Automatic Clinical Blood Chemistry Biochemistry Analyzer Bk-200

Name: Biobase Automatic Clinical Blood Chemistry Biochemistry Analyzer Bk-200
Brand: Biobase Biolin Co., Ltd.
SKU: 1972387022

Shandong, ChinaBiobase Biolin Co., Ltd.

US$2,500.00-3,500.00

1 Piece

Product profile

Customization

Available

Classification

Automatic Clinical Blood Chemistry Analyzer

Type

Biochemistry Analyzer

Model NO.

BK-200

Certification

Group

All People

Model

Bk-200

Throughput

200 Tests/Hour

Analysis Method

End-Point, Fixed-Time, Rate(Kinetic)

Sample Positions

37 Sample Positions

Reagent Position

28 Reagent Positions

Sample Volume

2-70µl

Reagent Volume

20-350µl

Probe

with Anti-Collision Function, Liqu

Probe Washing

Automatic Washing Interior and Exterior

Reagent Cooling

Refrigerated Tray with Independent Switch

Temperature Control

37+0.2℃, Real-Time Monitoring

Cuvettes

48 Reusable Cuvettes,Optical Length 6mm

Mixer Probe

Independent Stirring

Washing

Automatic Cuvettes Washing

Stat Function

Yes

Transport Package

Carton or Wooden Box

Specification

Package Size (W*D*H) 728*530*884mm

Trademark

BIOBASE

Origin

China

Production Capacity

50000pieces/Year

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceMulti-language PioneerExperienced Team

Biobase Biolin Co., Ltd.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 8.5 Years CertifiedNearest Port: Qingdao PortAverage Response Time: ≤3.90h

AI-Powered supplier vetting

SummaryThe supplier is identified as a limited trading company in Jinan, offering laboratory equipment, medical devices, biochemistry analyzers, autoclaves, biological safety cabinets, and related products. It reports ODM, OEM, professional technical, 3D design, and flexible customization capabilities, along with overseas service offerings and a stated export-sales share of 90%. Service procedures are mixed: complaint handling and corrective/preventive action procedures have records, while effective service-capability assessment procedures lack written procedures and records. No overseas showroom, agent, branch, offline trade-show participation, SDK, or new-product launch is reported. Production quantities are stated for three products, but the supplier’s manufacturing status is unclear because it is classified as a trading company.

Supplier typeThe supplier is explicitly classified as a Trading Company and Limited Company, with a business scope centered on sales of medical equipment, office supplies, software, electronic products, and related items. It is not identified as part of a larger company group, and its associated industry is wholesale and retail.

After-Sales capabilityThe supplier reports overseas training, equipment installation, repair, maintenance, and debugging services, with 10 qualified service suppliers and stated lead times of within 15 working days off-season and one month during peak season. Complaint handling and corrective/preventive-action procedures have records, but the assessment procedure for effective service capability lacks written procedures and records; there are also no overseas showrooms, agents, branches, or offline trade-show experience.

R&D capabilityThe supplier reports ODM service, professional technical R&D capability, 3D software design, and flexible customization. However, it reports no new products launched in the past year and no available SDK, while product-information R&D capability is also marked as absent.

Customization capabilityThe supplier explicitly provides ODM services, 3D software design services, and flexible customization through its design and R&D capabilities. These statements directly support the availability of customized design or product solutions.